Literature DB >> 18408907

[Simple and complex post-traumatic stress disorders. Diagnostic and therapeutic approaches].

C Roestel1, A Kersting.   

Abstract

The prevalence rates of post-traumatic stress disorders are high in the general population (5-10%). The main diagnostic criteria include the experience of an event of extraordinary threat and the persistence of specific symptoms such as intrusion, avoidance, and physiological hyperarousal. Long-lasting traumata may lead to the development of complex syndromes or irreversible personality alterations. Chronic manifestations, psychiatric comorbidities, and psychosocial deficits are special risks in the course of post-traumatic stress disorders. Severe traumata are associated with complex neurobiological changes. Psychotherapeutic approaches are established as a three-stage model: stabilisation, trauma reorientation, and psychosocial reintegration. The additional use of psychotropic drugs should be oriented to the specific symptomatology.

Entities:  

Mesh:

Year:  2008        PMID: 18408907     DOI: 10.1007/s00115-008-2442-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  28 in total

Review 1.  Dissociation, somatization, and affect dysregulation: the complexity of adaptation of trauma.

Authors:  B A van der Kolk; D Pelcovitz; S Roth; F S Mandel; A McFarlane; J L Herman
Journal:  Am J Psychiatry       Date:  1996-07       Impact factor: 18.112

2.  Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.

Authors:  Jonathan Davidson; David Baldwin; Dan J Stein; Enrique Kuper; Isma Benattia; Saeed Ahmed; Ron Pedersen; Jeff Musgnung
Journal:  Arch Gen Psychiatry       Date:  2006-10

3.  N-Acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD.

Authors:  M D De Bellis; M S Keshavan; S Spencer; J Hall
Journal:  Am J Psychiatry       Date:  2000-07       Impact factor: 18.112

4.  Preliminary study of carbamazepine in post-traumatic stress disorder.

Authors:  S Lipper; J R Davidson; T A Grady; J D Edinger; E B Hammett; S L Mahorney; J O Cavenar
Journal:  Psychosomatics       Date:  1986-12       Impact factor: 2.386

5.  Regional cerebral blood flow during script-driven imagery in childhood sexual abuse-related PTSD: A PET investigation.

Authors:  L M Shin; R J McNally; S M Kosslyn; W L Thompson; S L Rauch; N M Alpert; L J Metzger; N B Lasko; S P Orr; R K Pitman
Journal:  Am J Psychiatry       Date:  1999-04       Impact factor: 18.112

6.  Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study.

Authors:  S L Rauch; P J Whalen; L M Shin; S C McInerney; M L Macklin; N B Lasko; S P Orr; R K Pitman
Journal:  Biol Psychiatry       Date:  2000-05-01       Impact factor: 13.382

Review 7.  Psychological treatments for chronic post-traumatic stress disorder. Systematic review and meta-analysis.

Authors:  Jonathan I Bisson; Anke Ehlers; Rosa Matthews; Stephen Pilling; David Richards; Stuart Turner
Journal:  Br J Psychiatry       Date:  2007-02       Impact factor: 9.319

8.  Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder.

Authors:  J R Davidson; B O Rothbaum; B A van der Kolk; C R Sikes; G M Farfel
Journal:  Arch Gen Psychiatry       Date:  2001-05

9.  Reduced hippocampal volume and total white matter volume in posttraumatic stress disorder.

Authors:  Gerardo Villarreal; Derek A Hamilton; Helen Petropoulos; Ira Driscoll; Laura M Rowland; Jaqueline A Griego; Piyadasa W Kodituwakku; Blaine L Hart; Rodrigo Escalona; William M Brooks
Journal:  Biol Psychiatry       Date:  2002-07-15       Impact factor: 13.382

10.  Posttraumatic stress disorder in the National Comorbidity Survey.

Authors:  R C Kessler; A Sonnega; E Bromet; M Hughes; C B Nelson
Journal:  Arch Gen Psychiatry       Date:  1995-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.